Jefferies Positive on Intuitive Surgical (ISRG) Into Q3 Print
Get Alerts ISRG Hot Sheet
Rating Summary:
27 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 10
Join SI Premium – FREE
Jefferies analyst Imron Zafar reiterated a Buy rating and $500 price target on Intuitive Surgical (NASDAQ: ISRG) into Q3 results after the close on October 21st, following hospital/surgeon checks.
Zafar commented, "Our checks ahead of 3Q results point to encouraging trends/prospects for both placements and utilization. In this note, we present our latest thoughts, informed by recent hospital/surgeon due diligence. With continued Xi momentum, core market stabilization, and inroads in emerging procedures/geographies, estimates appear achievable and LT prospects remain compelling – supporting our Buy rating."
For an analyst ratings summary and ratings history on Intuitive Surgical click here. For more ratings news on Intuitive Surgical click here.
Shares of Intuitive Surgical closed at $470.24 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Downgrades NIBE Industrier AB (NIBEB:SW) (NDRBF) to Equalweight
- Piper Sandler Starts SI-BONE Inc. (SIBN) at Overweight, 'would recommend investors own the name'
- RBC Capital Starts Jasper Therapeutics (JSPR) at Outperform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!